TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/29/24 10:39 | 3/28/24 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Haddadin Yezan Munther | NJ | D | P | 22 | 11.82 | 0 | 2 | 59 | 5 | D | |||||||||||||||
10/11/22 17:05 | 10/6/22 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Haddadin Yezan Munther | NJ | D | P.m | 43 | 1.29 | 0 | 33 | 111 | 63 | D | |||||||||||||||
12/2/21 17:09 | 12/2/21 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Haddadin Yezan Munther | NJ | D | P | 14 | 1.39 | 0 | 10 | 50 | 30 | D | |||||||||||||||
4/20/21 19:56 | 4/19/21 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Haddadin Yezan Munther | NJ | D | P | 18 | 1.82 | 0 | 10 | 100 | 20 | D | |||||||||||||||
9/22/20 17:14 | 9/22/20 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Haddadin Yezan Munther | NJ | D | P | 7 | 0.7245 | 0 | 10 | New | 10 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |